Interleukin (il)-6 And Receptor Activator Of Nuclear Factor (nf)-Kappab Ligand (rankl) Are Increased In The Serum Of A Patient With Primary Pachydermoperiostosis (285 visite)
Scand J Rheumatol (ISSN: 0300-9742), 2008 May; 37(3): 225-229.
Tipo di articolo: Journal Article,
Impact factor: 2.345, Impact factor a 5 anni: 2.455
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-45549109228&partnerID=40&md5=852d3bd9b96f832855dd67049b0ef53b
Parole chiave: Interleukin 6, Osteoclast Differentiation Factor, Tnfsf11 Protein, Human, Alkaline Phosphatase Bone Isoenzyme, Colchicine, Nonsteroid Antiinflammatory Agent, Technetium 99m, Adolescent, Article, Blood, Case Report, Osteoarthropathy, Radiography, Scintiscanning, Adult, Anamnesis, Bone Scintiscanning, Bone Turnover, Capillaroscopy, Clinical Feature, Hormone Blood Level, Nuclear Magnetic Resonance Imaging, Osteolysis, Physical Examination, Primary Pachydermoperiostosis, Priority Journal, Primary Hypertrophic, Rank Ligand,
Affiliazioni:
*** IBB - CNR ***
Department of Clinical and Experimental Medicine, 'Federico II' University Medical School, Naples, Italy
Paediatric Endocrinology Unit, A.O.R.N. 'G. Rummo', Benevento, Italy
Department of Biomorphological and Functional Science, Department of Diagnostic Imaging and Radiotherapy, 'Federico II' University Medical School, Naples, Italy
National Research Council (CNR) Biostructures and Bioimaging Institute, 'Federico II' University Medical School, Naples, Italy
Medical Genetics Unit, A.O.R.N. 'G. Rummo', Benevento, Italy
Riferimenti:
Castori, M., Sinibaldi, L., Mingarelli, R., Lachman, R.S., Rimoin, D.L., Dallapiccola, B., Pachydermoperiostosis: An update (2005) Clin Gen, 68, pp. 477-48
Auger, M., Stavrianeas, N., Pachydermoperiostosis (2004) Orphanet encyclopedia, , www.orpha.net, Available from:, accessed December 2006
White, M.P., Hereditary metabolic and dysplastic skeletal disorders (2002) Disorders of bone and mineral metabolism, pp. 937-985. , Coe FL, Favus MJ, editors, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins
Jajic, Z., Jajic, I., Nemcic, T., Primary hypertrophic osteoarthropathy: Clinical, radiologic, and scintigraphic characteristics (2001) Arch Med Res, 32, pp. 136-142
Jajic, I., Jajic, Z., Grazio, S., Minor but important symptoms and signs in primary hypertrophic osteoarthropathy (2001) Clin Exp Rheumatol, 19, pp. 357-358
Hughes, H.E., McAlpine, P.J., Cox, D.W., Philipps, S., An autosomal dominant syndrome with 'acromegaloid' features and thickened oral mucosa (1985) J Med Genet, 22, pp. 119-125
Pichler, G., Eber, E., Thalhammer, G., Muntean, W., Zach, M.S., Arthralgia and digital clubbing in a child: Hypertrophic osteoarthropathy with inflammatory pseudotumour of the lung (2004) Scand J Rheumatol, 33, pp. 189-191
Oikarinen, A., Palatsi, R., Kylmaniemi, M., Keski-Oja, J., Risteli, J., Kallioinen, M., Pachydermoperiostosis: Analysis of the connective tissue abnormality in one family (1994) J Am Acad Dermatol, 31, pp. 947-953
Silveri, F., De Angelis, R., Argentati, F., Brecciaroli, D., Muti, S., Cervini, C., Hypertrophic osteoarthropathy: Endothelium and platelet function (1996) Clin Rheumatol, 15, pp. 435-439
Silveira, L.H., Martinez-Lavin, M., Pineda, C., Fonseca, M.C., Navarro, C., Nava, A., Vascular endothelial growth factor and hypertrophic osteoarthropathy (2000) Clin Exp Rheumatol, 18, pp. 57-62
Matucci-Cerinic, M., Martinez-Lavin, M., Rojo, F., Fonseca, C., Kahaleh, B.M., von Willebrand factor antigen in hypertrophic osteoarthropathy (1992) J Rheumatol, 19, pp. 765-767
Fam, A.G., Chin-Sang, H., Ramsay, C.A., Pachydermoperiostosis: Scintigraphic, thermographic, plethysmographic, and capillaroscopic observations (1983) Ann Rheum Dis, 42, pp. 98-102
Kallen, K.J., The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases (2002) Biochim Biophys Acta, 1592, pp. 323-334
Jostock, T., Mullberg, J., Ozbek, S., Atreya, R., Blinn, G., Voltz, N., Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses (2001) Eur J Biochem, 268, pp. 160-167
Boyle, W.J., Simonet, W.S., Lacey, D.L., Osteoclast differentiation and activation (2003) Nature, 423, pp. 337-342
Franchimont, N., Wertz, S., Malaise, M., Interleukin-6: An osteotropic factor influencing bone formation? (2005) Bone, 37, pp. 601-606
Jones, S.A., Rose-John, S., The role of soluble receptors in cytokine biology: The agonistic properties of the sIL-6R/IL-6 complex (2002) Biochim Biophys Acta, 1592, pp. 251-263
Kwan Tat, S., Padrines, M., Theoleyre, S., Heymann, D., Fortun, Y., IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology (2004) Cytokine Growth Factor Rev, 15, pp. 49-60
Mossetti, G., Rendina, D., De Filippo, G., Viceconti, R., Di Domenico, G., Cioffi, M., Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: Relationship to risedronate treatment (2005) Bone, 36, pp. 549-554
Angelo, L.S., Kurzrock, R., Vascular endothelial growth factor and its relationship to inflammatory mediators (2007) Clin Cancer Res, 13, pp. 2825-2830
Knudsen, L.S., Ostergaard, M., Baslund, B., Narvestad, E., Petersen, J., Nielsen, H.J., Plasma IL-6, plasma VEGF, and serum YKL-40: Relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate (2006) Scand J Rheumatol, 35, pp. 489-491
Brandi, M.L., Collin-Osdoby, P., Vascular biology and the skeleton (2006) J Bone Miner Res, 21, pp. 183-192
Roodman, G.D., Treatment strategies for bone disease (2007) Bone Marrow Transplant, 4, pp. 1139-1146
White, M. P., Hereditary metabolic and dysplastic skeletal disorders (2002) Disorders of bone and mineral metabolism, pp. 937-985. , Coe FL, Favus MJ, editors, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins
Hughes, H. E., McAlpine, P. J., Cox, D. W., Philipps, S., An autosomal dominant syndrome with 'Acromegaloid' features and thickened oral mucosa (1985) J Med Genet, 22, pp. 119-125
Silveira, L. H., Martinez-Lavin, M., Pineda, C., Fonseca, M. C., Navarro, C., Nava, A., Vascular endothelial growth factor and hypertrophic osteoarthropathy (2000) Clin Exp Rheumatol, 18, pp. 57-62
Fam, A. G., Chin-Sang, H., Ramsay, C. A., Pachydermoperiostosis: Scintigraphic, thermographic, plethysmographic, and capillaroscopic observations (1983) Ann Rheum Dis, 42, pp. 98-102
Kallen, K. J., The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases (2002) Biochim Biophys Acta, 1592, pp. 323-334
Boyle, W. J., Simonet, W. S., Lacey, D. L., Osteoclast differentiation and activation (2003) Nature, 423, pp. 337-342
Jones, S. A., Rose-John, S., The role of soluble receptors in cytokine biology: The agonistic properties of the sIL-6R/IL-6 complex (2002) Biochim Biophys Acta, 1592, pp. 251-263
Angelo, L. S., Kurzrock, R., Vascular endothelial growth factor and its relationship to inflammatory mediators (2007) Clin Cancer Res, 13, pp. 2825-2830
Knudsen, L. S., Ostergaard, M., Baslund, B., Narvestad, E., Petersen, J., Nielsen, H. J., Plasma IL-6, plasma VEGF, and serum YKL-40: Relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate (2006) Scand J Rheumatol, 35, pp. 489-491
Brandi, M. L., Collin-Osdoby, P., Vascular biology and the skeleton (2006) J Bone Miner Res, 21, pp. 183-192
Roodman, G. D., Treatment strategies for bone disease (2007) Bone Marrow Transplant, 4, pp. 1139-1146
Scand J Rheumatol (ISSN: 0300-9742), 2008 May; 37(3): 225-229.
Tipo di articolo: Journal Article,
Impact factor: 2.345, Impact factor a 5 anni: 2.455
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-45549109228&partnerID=40&md5=852d3bd9b96f832855dd67049b0ef53b
Parole chiave: Interleukin 6, Osteoclast Differentiation Factor, Tnfsf11 Protein, Human, Alkaline Phosphatase Bone Isoenzyme, Colchicine, Nonsteroid Antiinflammatory Agent, Technetium 99m, Adolescent, Article, Blood, Case Report, Osteoarthropathy, Radiography, Scintiscanning, Adult, Anamnesis, Bone Scintiscanning, Bone Turnover, Capillaroscopy, Clinical Feature, Hormone Blood Level, Nuclear Magnetic Resonance Imaging, Osteolysis, Physical Examination, Primary Pachydermoperiostosis, Priority Journal, Primary Hypertrophic, Rank Ligand,
Affiliazioni:
*** IBB - CNR ***
Department of Clinical and Experimental Medicine, 'Federico II' University Medical School, Naples, Italy
Paediatric Endocrinology Unit, A.O.R.N. 'G. Rummo', Benevento, Italy
Department of Biomorphological and Functional Science, Department of Diagnostic Imaging and Radiotherapy, 'Federico II' University Medical School, Naples, Italy
National Research Council (CNR) Biostructures and Bioimaging Institute, 'Federico II' University Medical School, Naples, Italy
Medical Genetics Unit, A.O.R.N. 'G. Rummo', Benevento, Italy
Riferimenti:
Castori, M., Sinibaldi, L., Mingarelli, R., Lachman, R.S., Rimoin, D.L., Dallapiccola, B., Pachydermoperiostosis: An update (2005) Clin Gen, 68, pp. 477-48
Auger, M., Stavrianeas, N., Pachydermoperiostosis (2004) Orphanet encyclopedia, , www.orpha.net, Available from:, accessed December 2006
White, M.P., Hereditary metabolic and dysplastic skeletal disorders (2002) Disorders of bone and mineral metabolism, pp. 937-985. , Coe FL, Favus MJ, editors, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins
Jajic, Z., Jajic, I., Nemcic, T., Primary hypertrophic osteoarthropathy: Clinical, radiologic, and scintigraphic characteristics (2001) Arch Med Res, 32, pp. 136-142
Jajic, I., Jajic, Z., Grazio, S., Minor but important symptoms and signs in primary hypertrophic osteoarthropathy (2001) Clin Exp Rheumatol, 19, pp. 357-358
Hughes, H.E., McAlpine, P.J., Cox, D.W., Philipps, S., An autosomal dominant syndrome with 'acromegaloid' features and thickened oral mucosa (1985) J Med Genet, 22, pp. 119-125
Pichler, G., Eber, E., Thalhammer, G., Muntean, W., Zach, M.S., Arthralgia and digital clubbing in a child: Hypertrophic osteoarthropathy with inflammatory pseudotumour of the lung (2004) Scand J Rheumatol, 33, pp. 189-191
Oikarinen, A., Palatsi, R., Kylmaniemi, M., Keski-Oja, J., Risteli, J., Kallioinen, M., Pachydermoperiostosis: Analysis of the connective tissue abnormality in one family (1994) J Am Acad Dermatol, 31, pp. 947-953
Silveri, F., De Angelis, R., Argentati, F., Brecciaroli, D., Muti, S., Cervini, C., Hypertrophic osteoarthropathy: Endothelium and platelet function (1996) Clin Rheumatol, 15, pp. 435-439
Silveira, L.H., Martinez-Lavin, M., Pineda, C., Fonseca, M.C., Navarro, C., Nava, A., Vascular endothelial growth factor and hypertrophic osteoarthropathy (2000) Clin Exp Rheumatol, 18, pp. 57-62
Matucci-Cerinic, M., Martinez-Lavin, M., Rojo, F., Fonseca, C., Kahaleh, B.M., von Willebrand factor antigen in hypertrophic osteoarthropathy (1992) J Rheumatol, 19, pp. 765-767
Fam, A.G., Chin-Sang, H., Ramsay, C.A., Pachydermoperiostosis: Scintigraphic, thermographic, plethysmographic, and capillaroscopic observations (1983) Ann Rheum Dis, 42, pp. 98-102
Kallen, K.J., The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases (2002) Biochim Biophys Acta, 1592, pp. 323-334
Jostock, T., Mullberg, J., Ozbek, S., Atreya, R., Blinn, G., Voltz, N., Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses (2001) Eur J Biochem, 268, pp. 160-167
Boyle, W.J., Simonet, W.S., Lacey, D.L., Osteoclast differentiation and activation (2003) Nature, 423, pp. 337-342
Franchimont, N., Wertz, S., Malaise, M., Interleukin-6: An osteotropic factor influencing bone formation? (2005) Bone, 37, pp. 601-606
Jones, S.A., Rose-John, S., The role of soluble receptors in cytokine biology: The agonistic properties of the sIL-6R/IL-6 complex (2002) Biochim Biophys Acta, 1592, pp. 251-263
Kwan Tat, S., Padrines, M., Theoleyre, S., Heymann, D., Fortun, Y., IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology (2004) Cytokine Growth Factor Rev, 15, pp. 49-60
Mossetti, G., Rendina, D., De Filippo, G., Viceconti, R., Di Domenico, G., Cioffi, M., Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: Relationship to risedronate treatment (2005) Bone, 36, pp. 549-554
Angelo, L.S., Kurzrock, R., Vascular endothelial growth factor and its relationship to inflammatory mediators (2007) Clin Cancer Res, 13, pp. 2825-2830
Knudsen, L.S., Ostergaard, M., Baslund, B., Narvestad, E., Petersen, J., Nielsen, H.J., Plasma IL-6, plasma VEGF, and serum YKL-40: Relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate (2006) Scand J Rheumatol, 35, pp. 489-491
Brandi, M.L., Collin-Osdoby, P., Vascular biology and the skeleton (2006) J Bone Miner Res, 21, pp. 183-192
Roodman, G.D., Treatment strategies for bone disease (2007) Bone Marrow Transplant, 4, pp. 1139-1146
White, M. P., Hereditary metabolic and dysplastic skeletal disorders (2002) Disorders of bone and mineral metabolism, pp. 937-985. , Coe FL, Favus MJ, editors, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins
Hughes, H. E., McAlpine, P. J., Cox, D. W., Philipps, S., An autosomal dominant syndrome with 'Acromegaloid' features and thickened oral mucosa (1985) J Med Genet, 22, pp. 119-125
Silveira, L. H., Martinez-Lavin, M., Pineda, C., Fonseca, M. C., Navarro, C., Nava, A., Vascular endothelial growth factor and hypertrophic osteoarthropathy (2000) Clin Exp Rheumatol, 18, pp. 57-62
Fam, A. G., Chin-Sang, H., Ramsay, C. A., Pachydermoperiostosis: Scintigraphic, thermographic, plethysmographic, and capillaroscopic observations (1983) Ann Rheum Dis, 42, pp. 98-102
Kallen, K. J., The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases (2002) Biochim Biophys Acta, 1592, pp. 323-334
Boyle, W. J., Simonet, W. S., Lacey, D. L., Osteoclast differentiation and activation (2003) Nature, 423, pp. 337-342
Jones, S. A., Rose-John, S., The role of soluble receptors in cytokine biology: The agonistic properties of the sIL-6R/IL-6 complex (2002) Biochim Biophys Acta, 1592, pp. 251-263
Angelo, L. S., Kurzrock, R., Vascular endothelial growth factor and its relationship to inflammatory mediators (2007) Clin Cancer Res, 13, pp. 2825-2830
Knudsen, L. S., Ostergaard, M., Baslund, B., Narvestad, E., Petersen, J., Nielsen, H. J., Plasma IL-6, plasma VEGF, and serum YKL-40: Relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate (2006) Scand J Rheumatol, 35, pp. 489-491
Brandi, M. L., Collin-Osdoby, P., Vascular biology and the skeleton (2006) J Bone Miner Res, 21, pp. 183-192
Roodman, G. D., Treatment strategies for bone disease (2007) Bone Marrow Transplant, 4, pp. 1139-1146
Primary pachydermoperiostosis (PDP) is a rare syndrome, characterized by digital clubbing, periostosis, and pachydermia. We have evaluated biochemical bone turnover markers, including components of interleukin-6 (IL-6) and osteoprotegerin/receptor activator of nuclear factor (NF)-κB ligand (OPG/RANKL) systems, in an 18-year-old man affected by primary PDP. The acute phase of the disease was characterized in our patient by high serum levels of IL-6 and RANKL. The observed high serum levels of these parameters are associated with increased values in markers of bone resorption (degradation products of C-terminal telopeptides of type-I collagen and urinary hydroxyproline/creatinine ratio) and reduced serum levels of bone alkaline phosphatase, a marker of bone formation. Serum levels of osteotrophic hormones were in the normal range. Our data suggest that, despite the radiographic findings, the acute phase of primary PDP is characterized by increased bone resorption, probably mediated by IL-6 and RANKL. © 2008 Taylor & Francis on license from Scandinavian Rheumatology Research Foundation.
Nessun risultato. |
Nessun risultato. |
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (143 visite)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Carbone F, Quarantelli M, Bruzzese D, Carotenuto A, De RosaV, Colamatteo A, Micillo T, De Luca Picione C, Saccà F, De Rosa A, Moccia M, Brescia Morra V, Matarese G
* Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a (142 visite)
Clin Immunol (ISSN: 1521-6616), 2017 Oct; 183: 249-253.
Impact Factor: 3.557
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (256 visite)
J Bone Miner Metab (ISSN: 0914-8779), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A
* Nuclear Cardiology in Heart Failure (239 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2014 Jan; 7(3): 1-7.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Gallicchio R, Pellegrino T, Nardelli A, Capacchione D, Sirignano C, Pace L
* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (228 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
Dettagli Esporta in BibTeX Esporta in EndNote
Dolga AM, Letsche T, Gold M, Doti N, Bacher M, Chiamvimonvat N, Dodel R, Culmsee C
* Activation of KCNN3/SK3/K(Ca)2. 3 channels attenuates enhanced calcium influx and inflammatory cytokine production in activated microglia (316 visite)
Glia (ISSN: 1098-1136), 2012 Dec; 60(12): 2050-2064.
Impact Factor: 5.466
Dettagli Esporta in BibTeX Esporta in EndNote
Galdiero S, Falanga A, Cantisani M, Tarallo R, della Pepa ME, D'Oriano V, Galdiero M
* Microbe-Host Interactions: Structure and Role of Gram-Negative Bacterial Porins (219 visite)
Curr Protein Pept Sci (ISSN: 1389-2037), 2012 Dec; 13(8): 843-854.
Impact Factor: 2.326
Dettagli Esporta in BibTeX Esporta in EndNote
Cantisani M, Vitiello M, Falanga A, Finamore E, Galdiero M, Galdiero S
* Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity (322 visite)
Int J Nanomed (ISSN: 1178-2013, 1176-9114, 1178-2013electronic), 2012; 7: 2361-2371.
Impact Factor: 3.463
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Costanzo P, Acampa W, Imbriaco M, Ferro A, Filardi PP, Cuocolo A
* Noninvasive assessment of coronary anatomy and myocardial perfusion: Going toward an integrated imaging approach (183 visite)
J Cardiovasc Med (ISSN: 1558-2027, 1558-2035), 2008 Oct; 9(10): 977-986.
Impact Factor: 1.407
Dettagli Esporta in BibTeX Esporta in EndNote
Sciacca MFM, Pappalardo M, Milardi D, Grasso DM, La Rosa C
* Calcium-Activated Membrane Interaction Of The Islet Amyloid Polypeptide: Implications In The Pathogenesis Of Type Ii Diabetes Mellitus (363 visite)
Arch Biochem Biophys, 2008 Sep 15; 65(1-2): 291-298.
Impact Factor: 3.043
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Soricelli A, Storto G, Cuocolo A
* Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers (223 visite)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2008 May; 15(3): 456-465.
Impact Factor: 2.442
Dettagli Esporta in BibTeX Esporta in EndNote
Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, Edenbrandt L, Flotats A, Germano G, Stopar TG, Franken P, Kelion A, Kjaer A, Le Guludec D, Ljungberg M, Maenhout AF, Marcassa C, Marving J, Mckiddie F, Schaefer WM, Stegger L, Underw
* EANM/ESC guidelines for radionuclide imaging of cardiac function (326 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Apr; 35(4): 851-885.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Scarpa R, Cuocolo A, Peluso R, Atteno M, Gisonni P, Iervolino S, Di Minno MND, Nicolai E, Salvatore M, Del Puente A
* Early psoriatic arthritis: the clinical spectrum (172 visite)
The Journal Of Rheumatology (ISSN: 0315-162x), 2008 Jan; 35(1): 137-141.
Impact Factor: 3.282
Dettagli Esporta in BibTeX Esporta in EndNote
Agostini S, Bolzati C, Didonè E, Cavazza-Ceccato M, Refosco F, Aloj L, Arra C, Aurilio M, Tornesello AL, Tesauro D, Morelli G
* The (Tc(N)(PNP))2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: In vitro and in vivo studies (233 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2007 Apr; 13(4): 211-219.
Impact Factor: 1.768
Dettagli Esporta in BibTeX Esporta in EndNote
Galdiero S, Vitiello M, Amodeo P, D'Isanto M, Cantisani M, Pedone C, Galdiero M
* Structural requirements for proinflammatory activity of porin P2 loop 7 from Haemophilus influenzae (301 visite)
Biochemistry (ISSN: 0006-2960, 1520-4995, 1520-4995electronic), 2006 Apr 11; 45(14): 4491-4501.
Impact Factor: 3.633
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Del Vecchio S, Salvatore M
* Technetium 99m sestamibi in multiple myeloma (145 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005 Jan; 234(1): 312-313.
Impact Factor: 5.377
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Del Vecchio S, Salvatore M, Walker RC, Angtuaco E, Sethi R, Fassas A, Barlogie B
* Technetium 99m sestamibi in multiple myeloma [3] (multiple letters) (212 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005; 234(1): 312-313.
Impact Factor: 5.377
Dettagli Esporta in BibTeX Esporta in EndNote
Borgatti M, Finotti A, Romanelli A, Saviano M, Bianchi N, Lampronti I, Lambertini E, Penolazzi L, Nastruzzi C, Mischiati C, Piva R, Pedone C, Gambari R
* Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression (238 visite)
Curr Drug Targets (ISSN: 1389-4501), 2004 Nov; 5(8): 735-744.
Impact Factor: 4.104
Dettagli Esporta in BibTeX Esporta in EndNote
Imbriaco M, Ferro A, Storto G, Pellegrino T, Sica G, Cuocolo A
* Early and late effects of coronary artery bypass grafting on cardiac haemodynamics during daily physical activities in patients with coronary artery disease (180 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Jun; 31(6): 852-856.
Impact Factor: 3.935
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M
* In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging (295 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004 Feb; 19(1): 93-98.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R
* 3. 0 T perfusion MR imaging (388 visite)
Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812.
Impact Factor: 0.023
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Evangelista L
* Nuclear medicine and positron emission tomography imaging in cardiology (284 visite)
Nucl Med Rev (ISSN: 1506-9680), 2003; 6(1): 59-63.
Impact Factor: 0.155
Dettagli Esporta in BibTeX Esporta in EndNote
Acampa W, Petretta M, Cuocolo A
* Nuclear medicine procedures in cardiovascular diseases: An evidence based approach (325 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2002 Dec; 46(4): 323-330.
Impact Factor: 1.903
Dettagli Esporta in BibTeX Esporta in EndNote
Manganelli F, Betocchi S, Ciampi Q, Storto G, Losi MA, Violante A, Briguori C, Tocchetti CG, Lombardi R, Cuocolo A, Chiariello M
* Myopia and IOP (199 visite)
Ann Ottalmol Clin Ocul, 2002 Jun 15; 115(10): 1053-1058.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Panico M, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M
* Radiolabeling approaches for cholecystokinin B receptor imaging (328 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2002; 66(6): 370-380.
Impact Factor: 2.372
Dettagli Esporta in BibTeX Esporta in EndNote
Ferro A, Salvatore M, Cuocolo A
* Radionuclide monitoring of left ventricular function after sublingual nifedipine administration at rest and during moderate physical activity (152 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2001 Sep; 8(6): 669-676.
Impact Factor: 1.868
Dettagli Esporta in BibTeX Esporta in EndNote
Acampa W, Petretta M, Cuocolo A
* Myocardial viability assessment in regions of left ventricular dysfunction. Part II: The present and future of echocardiography and magnetic resonance imaging (143 visite)
Nuclear Medicine Communications (ISSN: 0143-3636, 1473-5628), 2001 Jul; 22(7): 731-735.
Impact Factor: 1.19
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W
* Nuclear cardiology in the new millennium (184 visite)
Rev Esp Med Nucl (ISSN: 0212-6982), 2001 Jun; 20(4): 305-308.
Impact Factor: 0.155
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Storto G, Ferro A, Cuocolo A
* Radionuclide monitoring of left ventricular function (176 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2001; 8(5): 606-615.
Impact Factor: 1.868
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Rubini G, Acampa W, Nicolai E, Florimonte L, DiGiovine G, D'Addabbo A, Salvatore M
Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: Relation to thallium-201 activity and left ventricular function (149 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2000 May; 7(3): 235-241.
Impact Factor: 1.854
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Nicolai E, Pace L, Petretta M, Salvatore M
Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction (184 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2000 Jan; 7(1): 8-15.
Impact Factor: 1.854
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Salvatore M
Clinical imaging of multidrug resistance in cancer (239 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (203 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (172 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, Petretta M, Salvatore M
Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease (183 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 1998 May; 5(3): 265-274.
Impact Factor: 1.336
Dettagli Esporta in BibTeX Esporta in EndNote
Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer (198 visite)
Journal Of Clinical Oncology (ISSN: 0732-183x), 1998 May; 16(5): 1677-1683.
Impact Factor: 8.228
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Caracò C, Klain M, Varrella P, Acampa W, Muto P, Salvatore M
The role of radiolabeled somatostatin analogs in adrenal imaging (193 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 677-680.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (179 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Cuocolo A, Nicolai E, Imbriaco M, Maurea S, Nappi A, Ricciardelli B, Salvatore M
REVERSE REDISTRIBUTION IN TL-201 STRESS-REDISTRIBUTION MYOCARDIAL SCINTIGRAPHY - EFFECT OF REST REINJECTION (158 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1994 Nov; 19(11): 956-961.
Impact Factor: 0.34
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Cuocolo A, Pace L, Nicolai E, Nappi A, Imbriaco M, Trimarco B, Salvatore M
Left ventricular dysfunction in coronary artery disease: Comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging (161 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 1994 Jan; 1(1): 65-71.
Impact Factor: 1.878
Dettagli Esporta in BibTeX Esporta in EndNote
Imbriaco M, Cuocolo A, Pace L, Nicolai E, Nappi A, Celentano L, Palma G, Vosa C
Technetium-99m methoxy isobutyl isonitrile simultaneous evaluation of ventricular function and myocardial perfusion in patients with congenital heart disease (164 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1994 Jan; 19(1): 28-32.
Impact Factor: 0.34
Dettagli Esporta in BibTeX Esporta in EndNote
Nappi A, Cuocolo A, Iazzetta N, Ferrara LA, Marotta T, Pace L, Nicolai E, De Michele G, Campanella G, Salvatore M, Postiglione A
Ambulatory monitoring of left ventricular function in patients with Parkinson's disease and postural hypotension (467 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1994; 21(12): 1312-1317.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Cuocolo A, Pace L, Nicolai E, Nappi A, Imbriaco M, Morisco C, Chiariello M, Trimarco B, Salvatore M
Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis (166 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1993 Jun; 20(6): 502-510.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Mangoni Di Stefano SML, Pace L, Betocchi S, Imbriaco M, Cuocolo A, Chiariello M, Salvatore M
Left ventricular function related to age: Radionuclide angiography (132 visite)
Ital Curr Radiol (ISSN: 0394-1574), 1992; 11(1-2): 13-16.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Cuocolo A, Nappi A, Nicolai E, Imbriaco M, Mangoni di Santo Stefano ML, Salvatore M
Myocardial scintigraphy with technetium 99m methoxyisobutylisonitrile. A comparison with coronary arteriography in patients with suspected ischemic cardiopathy (191 visite)
Radiol Med (ISSN: 1826-6983, 0033-8362, 1826-6983electronic), 1992; 83(1-2): 97-100.
Impact Factor: 0.967
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Betocchi S, Pace L, Perrone-Filardi P, Chiariello M, Salvatore M
Quantitation of left ventricular asynchrony on radionuclide angiography phase images (223 visite) (PDF 150 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1990 Jul; 16(11): 801-806.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Vosa C, Lapenta L, Caianiello G, Esposito V, de LucaL, D'Angelo TS, Salvatore M
Pre- and postoperative Tc 99m scanning in monitoring pulmonary perfusion in the tetralogy of Fallot (250 visite)
Ital J Surg Sci (ISSN: 0392-3525), 1984; 14(1): 21-24.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
47 Records (46 escludendo Abstract e Conferenze).
Impact factor totale: 110.22 (107.812 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 130.169 (127.711 escludendo Abstract e Conferenze).
Impact factor totale: 110.22 (107.812 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 130.169 (127.711 escludendo Abstract e Conferenze).
Esporta in BibTeX Esporta in EndNote
Ultima modifica di Marco Comerci in data Thursday 19 March 2015, 12:24:55
285 visite. Ultima visita in data Monday 30 March 2020, 23:31:19
ibb.cnr.it